Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2011-6-27
pubmed:abstractText
RREB1 is an alternatively spliced transcription factor implicated in Ras signaling and cancer. Little is known about the expression of RREB1 isoforms in cell lines or human tumors, or about the clinical relevance of the latter. We have developed tools for IHC of RREB1 protein isoform-specific amplification of RREB1 mRNA and selective knockdown of RREB1 isoforms and use these to provide new information by characterizing RREB1 expression in bladder and prostate cancer cell lines and human tissue samples. Previously described splice variants RREB1?, RREB1?, RREB1?, and RREB1? were identified, as well as the novel variant RREB1?. Total and isoform-specific mRNA expression was lower in most but not all tumors, compared with normal tissues. RREB1 IHC performed on a bladder cancer TMA did not indicate a relationship between total RREB1 expression and overall survival after radical cystectomy for invasive bladder cancer. In contrast, in vitro proliferation studies using the UMUC-3 bladder cancer cell line after selective isoform-specific knockdown of expression indicate that RREB1? is not necessary for proliferation, but that RREB1? may be required. These contributions should accelerate progress in the nascent RREB1 field by providing new reagents while also providing clues to the role of RREB1 isoforms in human cancer and raising the possibility of isoform-specific roles in human carcinogenesis and progression.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1525-2191
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:volume
179
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
477-86
pubmed:meshHeading
pubmed-meshheading:21703425-Alternative Splicing, pubmed-meshheading:21703425-Blotting, Western, pubmed-meshheading:21703425-Cell Proliferation, pubmed-meshheading:21703425-Cystectomy, pubmed-meshheading:21703425-DNA-Binding Proteins, pubmed-meshheading:21703425-Humans, pubmed-meshheading:21703425-Immunoenzyme Techniques, pubmed-meshheading:21703425-Male, pubmed-meshheading:21703425-Neoplasm Invasiveness, pubmed-meshheading:21703425-Prognosis, pubmed-meshheading:21703425-Prostatic Neoplasms, pubmed-meshheading:21703425-Protein Isoforms, pubmed-meshheading:21703425-RNA, Messenger, pubmed-meshheading:21703425-RNA, Small Interfering, pubmed-meshheading:21703425-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:21703425-Survival Rate, pubmed-meshheading:21703425-Transcription Factors, pubmed-meshheading:21703425-Tumor Cells, Cultured, pubmed-meshheading:21703425-Urinary Bladder Neoplasms
pubmed:year
2011
pubmed:articleTitle
RREB1 transcription factor splice variants in urologic cancer.
pubmed:affiliation
Department of Molecular Physiology and Biological Physics, University of Virginia Health Sciences Center, Charlottesville, Virginia, USA.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural